It is now increasingly recognized that other post-translational modifications of PDH such as acetylation and glutathionylation are elevated in the setting of obesity [70], which can also contribute to the impairment of cardiac PDH activity [71,72]. The gene discussed is PDP1; the disease is obesity disorder.